Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-017665

Options or other derivatives

  • Chief Medical Officer acquired 104,890 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Daugherty Frank Joseph Chief Medical Officer 2022-06-22 Grant or award · Stock Options +104,890 104,890 D
Loading xslF345X03/ownership.xml…